← Back to Search

Device

Active tDCS with guided imagery for Chronic Pelvic Pain

N/A
Waitlist Available
Led By Kenneth M Peters, MD
Research Sponsored by William Beaumont Hospitals
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Study participants must have participated and completed: (IRB 2019-362) A Multi-Stage, Randomized, Single Blind, Pilot study of the Acute Effects of Guided Imagery and Transcranial Direct Current Stimulation (tDCS) on EEG Alpha Brain Waves and Pain Levels in Women with Chronic Pelvic Pain, referred to as Part
Female
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 1-week follow-up visit.
Awards & highlights

Study Summary

This trial is testing a possible new treatment for chronic pelvic pain that involves using a low electrical current to stimulate certain areas of the brain. Up to 20 women who have already participated in a related trial will receive 5 treatments and then be followed up with 1 week after to see how they respond.

Eligible Conditions
  • Chronic Pelvic Pain

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 1-week follow up visit.
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 1-week follow up visit. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
To assess changes in EEG alpha brain waves in women with CPP after 5 sessions of transcranial direct simulation (tDCS) administered concurrently with guided imagery (GI).
Secondary outcome measures
To assess changes in QOL in women with CPP after 5 sessions of transcranial direct simulation (tDCS) administered concurrently with guided imagery (GI).
To assess changes in pain in women with CPP after 5 sessions of transcranial direct simulation (tDCS) administered concurrently with guided imagery (GI).
To assess changes in urinary symptoms in women with CPP after 5 sessions of transcranial direct simulation (tDCS) administered concurrently with guided imagery (GI) as measured by the Interstitial Cystitis Symptom Index and Problem Index ICSI-PI).
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Active tDCS with guided imageryExperimental Treatment1 Intervention
Subjects will receive 2 miliamps of electrical stimulation to the brain (transcranial direct stimulation-tDCS) for 20 minutes concurrently while listening to a guided imagery CD specifically designed for women with chronic pelvic pain.

Find a Location

Who is running the clinical trial?

William Beaumont HospitalsLead Sponsor
149 Previous Clinical Trials
113,036 Total Patients Enrolled
Kenneth M Peters, MDPrincipal InvestigatorBeaumont Health
12 Previous Clinical Trials
4,320 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~0 spots leftby Mar 2025